Source:http://linkedlifedata.com/resource/pubmed/id/18852115
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2008-10-14
|
pubmed:abstractText |
We recently used RNA interference to show that a negative correlation of L-asparaginase (L-ASP) chemotherapeutic activity with asparagine synthetase (ASNS) expression in the ovarian subset of the NCI-60 cell line panel is causal. To determine whether that relationship would be sustained in a larger, more diverse set of ovarian cell lines, we have now measured ASNS mRNA expression using microarrays and a branched-DNA RNA assay, ASNS protein expression using an electrochemiluminescent immunoassay, and L-ASP activity using an MTS assay on 19 human ovarian cancer cell lines. Contrary to our previous findings, L-ASP activity was only weakly correlated with ASNS mRNA expression; Pearson's correlation coefficients were r = -0.21 for microarray data and r = -0.39 for the branched-DNA RNA assay, with just the latter being marginally statistically significant (P = 0.047, one-tailed). ASNS protein expression measured by liquid-phase immunoassay exhibited a much stronger correlation (r = -0.65; P = 0.0014, one-tailed). We conclude that ASNS protein expression measured by immunoassay is a strong univariate predictor of L-ASP activity in ovarian cancer cell lines. These findings provide rationale for evaluation of ASNS protein expression as a predictive biomarker of clinical L-ASP activity in ovarian cancer.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1535-7163
|
pubmed:author |
pubmed-author:BirrerMichael JMJ,
pubmed-author:GoldsmithPaul KPK,
pubmed-author:GunsiorMicheleM,
pubmed-author:HutchinsonAmy AAA,
pubmed-author:JiHelenH,
pubmed-author:KimHijooH,
pubmed-author:KohnElise CEC,
pubmed-author:LlamasJennyJ,
pubmed-author:LorenziPhilip LPL,
pubmed-author:OzbunLaurentL,
pubmed-author:ReinholdWilliam CWC,
pubmed-author:VarmaSudhirS,
pubmed-author:WeinsteinJohn NJN
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3123-8
|
pubmed:meshHeading |
pubmed-meshheading:18852115-Asparaginase,
pubmed-meshheading:18852115-Aspartate-Ammonia Ligase,
pubmed-meshheading:18852115-Cell Line, Tumor,
pubmed-meshheading:18852115-DNA Fingerprinting,
pubmed-meshheading:18852115-Female,
pubmed-meshheading:18852115-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18852115-Humans,
pubmed-meshheading:18852115-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:18852115-Ovarian Neoplasms,
pubmed-meshheading:18852115-RNA, Messenger,
pubmed-meshheading:18852115-Tumor Markers, Biological
|
pubmed:year |
2008
|
pubmed:articleTitle |
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.
|
pubmed:affiliation |
Genomics and Bioinformatics Group, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural,
Research Support, N.I.H., Intramural
|